Over the last 12 months the All Ordinaries index has carved out a gain of just over 6% including dividends.
Whilst that it is a decent return, some shares on the index have generated vastly superior returns over the same period.
The three shares listed below, for example, have more than doubled in value over the last 12 months. Here's why:
The Audinate (ASX: AD8) share price has rocketed 121% higher over the last 12 months. Investors have been buying the shares of the leading provider of digital Audio-Visual networking technologies due to the success of its key Dante audio over IP networking solution. Dante is an uncompressed, multi-channel digital media networking technology, with near-zero latency and synchronisation. It has quickly become the industry's preferred audio networking solution and has been adopted by more pro-audio AV manufacturers than any other networking technology. This has led to the company achieving stellar sales growth which has certainly caught the eye of many investors.
The CLINUVEL Pharmaceuticals Limited (ASX: CUV) share price has surged 129% higher since this time last year. The biopharmaceutical company's shares have been on fire due to the strong sales growth of its SCENESSE product. SCENESSE has been developed as a first-line pharmaceutical product aimed at treating patients with the rare genetic disorder erythropoietic protoporphyria (EPP). Last month the company reported cash receipts of $5.9 million for the March quarter. This was an increase of 126% on the previous quarter and 70% on the prior corresponding period. Pleasingly, its sales could be given a big boost in the near term if the U.S. FDA approves it for sale in the United States. CLINUVEL has a Priority Review meeting in July with the regulatory body.
The Nearmap Ltd (ASX: NEA) share price has raced a whopping 288% higher over the last 12 months. Investors have been scrambling to get hold of the aerial imagery technology and location data company's shares after it delivered further strong growth in FY 2019. In the first half of the financial year the company achieved revenue of $36.3 million, up 46% on the prior corresponding period. But perhaps the most impressive metric that the company reported was its 123% increase in total subscriber lifetime value to $1.07 billion. And with the company planning to expand into other countries, I expect this key metric to grow even further in FY 2020.
